129 related articles for article (PubMed ID: 31090188)
1. Association of Hepcidin With Anemia Parameters in Incident Dialysis Patients: Differences Between Dialysis Modalities.
Lim JH; Park YW; Lee SH; Do JY; Kim SH; Han S; Jung HY; Choi JY; Cho JH; Kim CD; Park SH; Kim YL
Ther Apher Dial; 2020 Feb; 24(1):4-16. PubMed ID: 31090188
[TBL] [Abstract][Full Text] [Related]
2. Hepcidin/Ferritin Ratios Differ Among Non-Dialyzed Chronic Kidney Disease Patients, and Patients on Hemodialysis and Peritoneal Dialysis.
Niikura T; Maruyama Y; Nakashima S; Matsuo N; Tanno Y; Ohkido I; Yokoyama K; Yamamoto H; Yokoo T
Ther Apher Dial; 2019 Aug; 23(4):341-346. PubMed ID: 30411489
[TBL] [Abstract][Full Text] [Related]
3. Serum hepcidin levels in patients with end-stage renal disease on hemodialysis.
Rubab Z; Amin H; Abbas K; Hussain S; Ullah MI; Mohsin S
Saudi J Kidney Dis Transpl; 2015 Jan; 26(1):19-25. PubMed ID: 25579711
[TBL] [Abstract][Full Text] [Related]
4. Serum hepcidin levels are associated with serum triglycerides and interleukin-6 concentrations in patients with end-stage renal disease.
Samouilidou E; Pantelias K; Petras D; Tsirpanlis G; Bakirtzi J; Chatzivasileiou G; Tzanatos H; Grapsa E
Ther Apher Dial; 2014 Jun; 18(3):279-83. PubMed ID: 24119290
[TBL] [Abstract][Full Text] [Related]
5. Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: a cross-sectional study.
Uehata T; Tomosugi N; Shoji T; Sakaguchi Y; Suzuki A; Kaneko T; Okada N; Yamamoto R; Nagasawa Y; Kato K; Isaka Y; Rakugi H; Tsubakihara Y
Nephrol Dial Transplant; 2012 Mar; 27(3):1076-83. PubMed ID: 21799206
[TBL] [Abstract][Full Text] [Related]
6. Hepcidin and diabetes are independently related with soluble transferrin receptor levels in chronic dialysis patients.
Belo L; Rocha S; Valente MJ; Coimbra S; Catarino C; Bronze-da-Rocha E; Rocha-Pereira P; do Sameiro-Faria M; Oliveira JG; Madureira J; Fernandes JC; Miranda V; Santos-Silva A
Ren Fail; 2019 Nov; 41(1):662-672. PubMed ID: 31296086
[No Abstract] [Full Text] [Related]
7. Relation of serum hepcidin levels and restless legs syndrome in chronic hemodialysis patients.
Tufekci A; Kara E
Sleep Breath; 2021 Jun; 25(2):897-905. PubMed ID: 33029690
[TBL] [Abstract][Full Text] [Related]
8. The relationship of Prohepcidin levels with anemia and inflammatory markers in non-diabetic uremic patients: a controlled study.
Aydin Z; Gursu M; Karadag S; Uzun S; Sumnu A; Doventas Y; Ozturk S; Kazancioglu R
Ren Fail; 2014 Sep; 36(8):1253-7. PubMed ID: 25040737
[TBL] [Abstract][Full Text] [Related]
9. Hepcidin and regulation of iron homeostasis in maintenance hemodialysis patients.
Sany D; Elsawy AE; Elshahawy Y
Saudi J Kidney Dis Transpl; 2014 Sep; 25(5):967-73. PubMed ID: 25193892
[TBL] [Abstract][Full Text] [Related]
10. Serum Hepcidin and Iron Indices Affect Anemia Status Differently According to the Kidney Function of Non-Dialysis Chronic Kidney Disease Patients: Korean Cohort Study For Outcome in Patients with Chronic Kidney Disease (KNOW-CKD).
Lee SW; Kim YH; Chung W; Park SK; Chae DW; Ahn C; Kim YS; Sung SA
Kidney Blood Press Res; 2017; 42(6):1183-1192. PubMed ID: 29227972
[TBL] [Abstract][Full Text] [Related]
11. Effect of increased blood flow rate on renal anemia and hepcidin concentration in hemodialysis patients.
Yamamoto M; Matsumoto T; Ohmori H; Takemoto M; Ikeda M; Sumimoto R; Kobayashi T; Kato A; Ohdan H
BMC Nephrol; 2021 Jun; 22(1):221. PubMed ID: 34126941
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein but not hepcidin, NGAL and transferrin determines the ESA resistance in hemodialysis patients.
Yılmaz I; Ozkok A; Kostek O; Kolukısa A; Duran I; Odabaş AR; Kemal Işman F; Işbilen Başok B
Ren Fail; 2016; 38(1):89-95. PubMed ID: 26539647
[TBL] [Abstract][Full Text] [Related]
13. Hepcidin and iron metabolism disorders in patients with chronic kidney disease.
Jelić M; Cvetković T; Djordjević V; Damnjanovć G; Vlahović P; Kocić G; Djindjić N; Jovović B; Antić A
Vojnosanit Pregl; 2013 Apr; 70(4):368-73. PubMed ID: 23700940
[TBL] [Abstract][Full Text] [Related]
14. Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis.
Honda H; Kobayashi Y; Onuma S; Shibagaki K; Yuza T; Hirao K; Yamamoto T; Tomosugi N; Shibata T
PLoS One; 2016; 11(3):e0151601. PubMed ID: 26978524
[TBL] [Abstract][Full Text] [Related]
15. Resistin hormone in diabetic kidney disease and its relation to iron status and hepcidin.
Hayder ZS; Kareem ZS
Int Urol Nephrol; 2020 Apr; 52(4):749-756. PubMed ID: 32173772
[TBL] [Abstract][Full Text] [Related]
16. HEPCIDIN AND IRON BIOMARKERS MODULATED IN HEMODIALYSIS PATIENTS.
Mohammed M; Sarhat E; Marbut M
Georgian Med News; 2023 Nov; (344):101-105. PubMed ID: 38236107
[TBL] [Abstract][Full Text] [Related]
17. Hepcidin-25, mean corpuscular volume, and ferritin as predictors of response to oral iron supplementation in hemodialysis patients.
Takasawa K; Takaeda C; Maeda T; Ueda N
Nutrients; 2014 Dec; 7(1):103-18. PubMed ID: 25551249
[TBL] [Abstract][Full Text] [Related]
18. The Different Association between Serum Ferritin and Mortality in Hemodialysis and Peritoneal Dialysis Patients Using Japanese Nationwide Dialysis Registry.
Maruyama Y; Yokoyama K; Yokoo T; Shigematsu T; Iseki K; Tsubakihara Y
PLoS One; 2015; 10(11):e0143430. PubMed ID: 26599216
[TBL] [Abstract][Full Text] [Related]
19. Comparison of serum levels of hepcidin and pro-hepcidin in hemodialysis patients and healthy subjects.
Taheri N; ; Mojerloo M; Hadad M; Mirkarimi H; Nejad RK; Joshaghani HR
Saudi J Kidney Dis Transpl; 2015 Jan; 26(1):34-8. PubMed ID: 25579713
[TBL] [Abstract][Full Text] [Related]
20. Serum hepcidin in haemodialysis patients: associations with iron status and microinflammation.
Xu Y; Ding XQ; Zou JZ; Liu ZH; Jiang SH; Chen YM
J Int Med Res; 2011; 39(5):1961-7. PubMed ID: 22118000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
